Sunday, September 13, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 17, 2026

JPMorgan Chase (JPM) Stock After 25% Yearly Gain Is The Price Still Reasonable

View original at finance.yahoo.com
JPMorgan Chase (JPM) Stock After 25% Yearly Gain Is The Price Still Reasonable Never miss an important update on your stock portfolio and cut through the noise…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Analysts estimate a stable earnings figure of US$24.65 per share and a stable book value of US$145.37 per share for JPMorgan Chase, based on forward-looking ROE inputs from 12 analysts

    60% confidence
  • Over 7 million investors trust Simply Wall St for stock portfolio updates

    60% confidence
  • JPMorgan Chase scores just 2 out of 6 on Simply Wall St's valuation checks, with multiple red flags identified

    60% confidence
  • JPMorgan Chase stock is approximately 24.0% undervalued based on the Excess Returns valuation model, with an intrinsic value estimate of US$435.81 per share versus a market price of US$331.14

    60% confidence
  • The average Return on Equity used in the Excess Returns model is 16.96%, with a cost of equity of US$11.65 per share and an excess return of US$13.00 per share

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Chip Boom Lifts Semiconductors as Export-Control Gaps Persist
AI infrastructure demand is fueling a broad semiconductor rally — Broadcom's AI chip revenue and Q4 guidance, Amazon's custom silicon crossing a $25B annual run rate, and bullish analyst calls on Micron and Sandisk tied to a memory chip boom underestimated even by bulls — with ASML rallying on sympathy. That momentum runs alongside unresolved US-China tech tensions: Belgium's arrest of a suspect for stealing chip technology for China and a blacklisted Chinese firm still acquiring Nvidia's top AI chips show export-control enforcement lagging the pace of AI chip demand.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com
JPMorgan Chase (JPM) Stock After 25% Yearly Gain Is The Price Still Reasonable — Source | Via News | Finance Via News